FAS and non-small cell lung carcinoma: Kaplan–Meier survival analysis using 1882 available NSCLC patients from the Kaplan–Meier Plotter showed that high expression of FAS is significantly associated with favorable prognosis of NSCLC patients (HR = 0.77, P = 6.5e-05) (Supplementary Fig. 2C).